U.S., Aug. 1 -- ClinicalTrials.gov registry received information related to the study (NCT07094932) titled 'A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of TBD09' on July 29.
Brief Summary: This is a randomized, double-blind, placebo-controlled, multiple dose trial of TBD09, administered to healthy adult participants to assess safety, tolerability, and pharmacokinetics up to 84 days of fixed daily dosing of TBD09. The trial will be conducted with two cohorts, with participants enrolled in parallel and randomized to receive either TBD09 or placebo.
Study Start Date: Sept. 12
Study Type: INTERVENTIONAL
Condition:
Healthy Adult Participants
Intervention:
DRUG: TBD09
TBD09 will be administered orally
DRUG: Placebo...